[NXY-059] could be a billion-dollar drug, because there are so many stroke victims.
Biotech takes big risks in areas of unmet need and they do that in an innovative way, ... As [Capt.] James Kirk [of the fictional starship Enterprise] says, it's not afraid to go where nobody else has gone before.
Biotech takes big risks in areas of unmet need and they do that in an innovative way. As [Capt.] James Kirk [of the fictional starship Enterprise] says, it's not afraid to go where nobody else has gone before.
It's encouraging. But it's all very preliminary.
It's exciting and the potential is enormous, but the challenges and the risks are formidable.
The Phase III results to date are not encouraging.
There's a perceived halo effect, which is negative, that we don't agree with. Each of the cancer vaccine companies should be viewed as different companies.
This news is driving investor interest in the area. My caution is that it's still emerging and it's hard to tell who is going to be the winners. I don't like people buying on the hype.
We believe that any intensive reading into the data at this stage may be premature,
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.
Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.